Author

Yongkang Xu

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

In situ macrophage reprogramming via micropatch engineering for safe and effective antitumor adoptive cell therapy.

By combining a straightforward micropatch engineering strategy with insights from single-cell sequencing, this approach offers a scalable, safe, and highly effective platform for macrophage-based adoptive cell therapy.

Yongkang Xu, Lei Cao, Yu-Yan Zhou et al. · Science Bulletin · 0 citations